Site logo

Archives

Sep 06
New Study Shows How AI is Revolutionizing Drug Development

Discover how AI is revolutionizing drug development for mental health disorders such as depression and schizophrenia.

Aug 15
Overdose Awareness Month: Say Their Names, Tell Their Stories

Honor those lost to overdose by raising awareness and sharing their stories during Overdose Awareness Month.

Aug 13
One-Third of U.S. Teens Now Receiving Mental Health Support, SAMHSA Study Shows

SAMHSA study reveals strides in adolescent mental health treatment and the importance of continued efforts in the field.

Aug 13
FDA Greenlights Review of Vertex’s Suzetrigine for Severe Acute Pain

FDA grants priority review and sets January 30, 2025 as the target action date under the Prescription Drug User Fee Act.

Aug 13
New Study Reveals Reasons Behind Doctors’ Hesitation in Prescribing Addiction Treatments

Discover barriers physicians face in addiction treatment and the necessary changes to improve intervention practices.

Jul 22
Landmark Funding for Women’s Behavioral Health

The U.S. Department of Health and Human Services (HHS), through the Substance Abuse and Mental Health Services Administration (SAMHSA), has announced substantial funding opportunities totaling $27.5 million to improve women’s behavioral health nationwide. In addition, nearly $1 million in grant awards have been allocated to two recipients as part of the Services Program for Residential […]

Jul 22
The Future of Overdose Prevention Centers in the U.S.

Discover how Overdose Prevention Centers are making a difference in the opioid epidemic by providing supervised drug use environments.

Jul 11
National Minority Mental Health Awareness Month

Join us this month as we spotlight the mental health challenges and triumphs within racial and ethnic minority communities in the United States. Discover systemic insights, celebrate resilience, and access essential resources for promoting mental well-being.

Jul 11
Supreme Court Blocks Purdue Pharma Settlement, Impacting Opioid Victim Compensation

In a landmark decision, the Supreme Court voided Purdue Pharma's bankruptcy plan, rejecting the legal protections for the Sackler family and casting uncertainty on billions of dollars meant for opioid victims. This 5-4 ruling will reshape the landscape of bankruptcy settlements and the pursuit of justice for those affected by opioid addiction.

Jun 13
What You Need to Know About Tianeptine 

Regulatory Differences Across Regions Tianeptine is often marketed under names like Coaxil or Stablon and is prescribed in some countries to treat depression and anxiety. However, the regulatory landscape varies significantly across different regions. In many Latin American, Asian, and European countries, tianeptine is prescribed for certain mental health conditions. In the United States, the […]